Effect of zinc supplementation versus control group on cellular immunity, treatment and relapse of brucellosis
Phase 2
- Conditions
- Brucellosis.Brucellosis
- Registration Number
- IRCT20120215009014N332
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Age of 15 to 60 years,
Acute brucellosis
Exclusion Criteria
Pregnancy,
History of brucellosis,
Complicated brucellosis,
Chronic diseases such as cardiovascular disease, anemia, bone carcinoma,
Concurrent with AIDS,
A history of collagen vascular disease,
A history of zinc use
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical symptoms. Timepoint: Before the intervention and 1 and 2 months later. Method of measurement: By taking history and physical examination.;Treatment of the disease. Timepoint: 1 and 2 months after the intervention. Method of measurement: by using 2ME test.;Relapse of the disease. Timepoint: 6 months after the intervention. Method of measurement: by using 2ME test.
- Secondary Outcome Measures
Name Time Method